Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Lidocaine vs Dexmedetomidine for Depressive Symptoms and Sleep After Breast Cancer Surgery
IRCT20250722066589N4Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer, major depressive episode (MDE), sleep disorder and 1 more comparing Perioperative lidocaine with Perioperative dexmedetomidine (2 arms). Started Jan 2026; status: completed.
02
Drugs
lidocainedexmedetomidine
03
Conditions
breast cancermajor depressive episode (MDE)sleep disordergeneralized anxiety disorder (GAD)
Beyond the preview
Go deeper on IRCT20250722066589N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250722066589N4.